A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic

Affiliations

¹ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK. Electronic address: v.speed@nhs.net.
² King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
³ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK.

V Speed et al. Thromb Res. 2020 Aug.

. 2020 Aug:192:73-74.

doi: 10.1016/j.thromres.2020.05.024. Epub 2020 May 16.

¹ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK. Electronic address: v.speed@nhs.net.
² King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
³ King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK.

No abstract available

Keywords: Anticoagulants; Coronavirus; Coumarins.

References

1. UK Office for National Statistics Coronavirus (COVID-19) in the UK. https://coronavirus.data.gov.uk/ Updated 19/4/2020.
1. Williams H. Guidance for the safe switching of warfarin to direct oral anticoagulants (DOACs) for patients with non-valvular AF and venous thromboembolism (DVT/PE) during the coronavirus pandemic. Royal College of General Practitioners and British Society of Haematology. 2020; 26 March Guidance for the safe switching of warfarin to direct oral anticoagulant...
1. Kaatz S., Ahmad D., Spyropoulos A., Schulman S., Subcommittee on Control of Anticoagulation Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J. Thromb. Haemost. 2015;13(11):2119–2126. - PubMed
1. Schulman S., Kearon C., Subcommittee on Control of Anticoagulation of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J. Thromb. Haemost. 2005;3(4):692–694. - PubMed
1. Public Health England. COVID-19 - investigation and initial clinical management of possible cases (updated 27/4/2020). https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initi.... Updated Accessed May 12, 2020.